Lessons learned from a comparison of evidence-based research in pregnant opioid-dependent women

Human Psychopharmacology

Volumn 28, Issue 1, 2013, Pages 15-24

  Winklbaur Hausknost, Bernadette ^a   Jagsch, Reinhold ^b   Graf Rohrmeister, Klaudia ^a   Unger, Annemarie ^a   Baewert, Andjela ^a   Langer, Martin ^a   Thau, Kenneth ^a   Fischer, Gabriele ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c Medical University of Vienna   (Austria)

Author keywords

buprenorphine; methadone; neonatal outcome; opioid dependence; pregnancy

Indexed keywords

BUPRENORPHINE; METHADONE; MORPHINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; DOUBLE BLIND PROCEDURE; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; OPIATE ADDICTION; PILOT STUDY; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT DURATION; URINALYSIS; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; BUPRENORPHINE; DOUBLE-BLIND METHOD; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; INFANT, NEWBORN; LEARNING; METHADONE; OPIOID-RELATED DISORDERS; PILOT PROJECTS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; YOUNG ADULT;

EID: 84873081408     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2275     Document Type: Article

References (51)

1. Almario CV, Seligman NS, Dysart KC, Berghella V, Baxter JK,. 2009. Risk factors for preterm birth among opiate-addicted gravid women in a methadone treatment program. Am J Obstet Gynecol 201 (3): 326.e1-6.
2. Baewert A, Jagsch R, Winklbaur B, et al,. 2012. Influence of site differences between urban and rural American and Central European opioid-dependent pregnant women and neonatal outcome characteristics. Eur Addict Res 18 (3): 130-9.
3. Bakstad B, Sarfi M, Welle-Strand GK, Ravndal E,. 2009. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study. Eur Addict Res 15 (3): 128-134.
4. Banti S, Mauri M, Oppo A, et al,. 2011. From the third month of pregnancy to 1 year postpartum. Prevalence, incidence, recurrence, and new onset of depression. Results from the perinatal depression-research & screening unit study. Compr Psychiatry 52 (4): 343-351.
5. Burns L, Mattick RP, Lim K, Wallace C,. 2007. Methadone in pregnancy: treatment retention and neonatal outcomes. Addiction 102 (2): 264-270.
6. Cleary BJ, Donnelly J, Strawbridge J, et al,. 2010. Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis. Addiction 105 (12): 2071-2084.
7. Clements KM, Barfield WD, Aydi MW, Wilber N,. 2007. Preterm birth-associated cost of early intervention services: an analysis by gestational age. Pediatrics 119 (4): e866-874.
8. Daley M, Argeriou M, McCarthy D, Callahan J J Jr, Shepard DS, Williams CN, 2001. The impact of substance abuse treatment modality on birth weight and health care expenditures. J Psychoact Drugs 3: 57-66.
9. Dickmann LJ, Isoherranen N,. 2012. Quantitative prediction of CYP2B6 induction by estradiol during pregnancy, potential explanation for increased methadone clearance during pregnancy. Drug Metab Dispos DOI: 10.1124/dmd.112.047118
10. Ebner N, Rohrmeister K, Winklbaur B, et al,. 2007. Management of neonatal abstinence syndrome in neonates born to opioid-maintained women. Drug Alcohol Depend 87 (2-3): 131-138.
11. Finnegan, LP, Kron, RE, Connaughton, JF, Emich, JP,. 1975. Assessment and treatment of abstinence in the infant of the drug dependent mother. International J Clin Pharm Biopharmacy 12: 19-32.
12. Fischer G, Etzersdorfer P, Eder H, Jagsch R, Langer M, Weninger M,. 1998. Buprenorphine maintenance in pregnant opiate addicts. Eur Addict Res 4 (Suppl 1): 32-36.
13. Fischer G, Johnson RE, Eder H, et al,. 2000. Treatment of opioid-dependent pregnant women with buprenorphine. Addiction 95 (2): 239-244.
14. Fischer G, Ortner R, Rohrmeister K, et al,. 2006. Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction 101: 275-281.
15. Goldenberg RL, Culhane JF, Iams JD, Romero R,. 2008. Epidemiology and causes of preterm birth. Lancet 371 (9606): 75-84.
16. Goldkind SF, Sahin L, Gallauresi B, 2010. Enrolling pregnant women in research - lessons from the H1N1 influenza pandemic N Engl J Med 362 (24): 2241-2243.
17. Haasen C, Prinzleve M, Zurhold H, et al,. 2004. Cocaine use in Europe-a multi-centre study. Methodology and prevalence estimates. Eur Addict Res 10 (4): 139-146.
18. Higgins ST, Heil SH, Solomon LJ, et al,. 2004. A pilot study on voucher-based incentives to promote abstinence from cigarette smoking during pregnancy and postpartum. Nicotine Tob Res 6: 1015-1020.
19. Jansson LM, Dipietro JA, Velez M, Elko A, Knauer H, Kivlighan KT,. 2009. Maternal methadone dosing schedule and fetal neurobehaviour. J Matern Fetal Neonatal Med 22 (1): 29-35.
20. Johnson K, Gerada C, Greenough A,. 2003a. Substance misuse during pregnancy. Br J Psychiatry 183: 187-189.
21. Johnson RE, Jones HE, Fischer G,. 2003b. Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend 70 (2 Suppl): 87-101.
22. Jones HE, Johnson RE, Jasinski DR, et al,. 2005. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend 79: 1-10.
23. Jones HE, Suess P, Jasinski DR, Johnson RE,. 2006. Transferring methadone-stabilized pregnant patients to buprenorphine using an immediate release morphine transition: an open-label exploratory study. Am J Addict 15 (1): 61-70.
24. Jones HE, Martin PR, Heil SH, et al,. 2008. Treatment of opioid-dependent pregnant women: clinical and research issues. J Subst Abuse Treat 35 (3): 245-259.
25. Jones HE, Kaltenbach K, Heil SH, et al,. 2010. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med 363 (24): 2320-2331.
26. Kakko J, Heilig M, Sarman I,. 2008. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series. Drug Alcohol Depend 96: 69-78.
27. Kayemba-Kay's S, Laclyde JP,. 2003. Buprenorphine withdrawal syndrome in newborns: a report of 13 cases. Addiction 98: 1599-1604.
28. Korvenranta E, Lehtonen L, Rantara L, et al,. 2010. Impact of very preterm birth on health care costs at five years of age. Pediatrics 125 (5): e1109-1114.
29. Kristensen Ø, Espegren O, Asland R, et al,. 2005. Buprenorphine and methadone to opiate addicts - a randomized trial. Tidsskr Nor Laegeforen 125 (2): 148-51.
30. Lacroix I, Berrebi A, Chaumerliac C, Lapeyre-Mestre M, Montastruc JL, Damase-Michel C,. 2004. Buprenorphine in pregnant opioid-dependent women: first results of a prospective study. Addiction 99: 209-214.
31. Lejeune C, Simmat-Durand L, Gourarier L, Aubisson S, Groupe d'Etudes Grossesse et Addictions [GEGA]. 2006. Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenorphine substitution. Drug Alcohol Depend 82: 250-257.
32. Ludlow JP, Evans SF, Hulse G,. 2004. Obstetric and perinatal outcomes in pregnancies associated with illicit substance abuse. Aust N Z J Obstet Gynaecol 44 (4): 302-306.
33. Metz V, Jagsch R, Ebner N, et al,. 2011. Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women. Hum Psychopharmacol DOI: 10.1002/hup.1224
34. Minozzi S, Amato L, Vecchi S, Davoli M,. 2008. Maintenance agonist treatments for opiate dependent pregnant women. Cochrane Database Syst Rev 16 (2): CD006318.
35. Peachey JE, Lei H,. 1988. Assessment of opioid dependence with naloxone. Br J Addict 83: 193-201.
36. Pedersen LH, Videbech P,. 2011. Use of antidepressants during pregnancy. Ugeskr Laeger 173 (15): 1118-1120.
37. Peles E, Schreiber S, Bloch M, Dollberg S, Adelson M,. 2012. Duration of methadone maintenance treatment during pregnancy and pregnancy outcome parameters in women with opiate addiction. J Addict Med 6 (1): 18-23
38. Pizarro D, Habli M, Grier M, Bombrys A, Sibai B, Livingston J,. 2011. Higher maternal doses of methadone does not increase neonatal abstinence syndrome. J Subst Abuse Treat 40 (3): 295-298.
39. Pond SM, Kreek MJ, Tong TG, Raghunath J, Benowitz NL,. 1985. Altered methadone pharmacokinetics in methadone-maintained pregnant women. JPET 233 1: 1-6.
40. Sarkar S, Donn SM,. 2006. Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. J Perinatol 26: 15-17.
41. Schempf AH, Strobino DM,. 2008. Illicit drug use and adverse birth outcomes: is it drugs or context? J Urban Health 85 (6): 858-873.
42. Schindler SD, Eder H, Ortner R, Rohrmeister K, Langer M, Fischer G,. 2003. Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy. Addiction 98 (1): 103-110.
43. Schroder R, Sellman D, Frampton C, Deering D,. 2009. Youth retention: factors associated with treatment drop-out from youth alcohol and other drug treatment. Drug Alcohol Rev 28 (6): 663-668.
44. Seligman NS, Almario CV, Hayes EJ, Dysart KC, Berghella V, Baxter JK,. 2010. Relationship between maternal methadone dose at delivery and neonatal abstinence syndrome. J Pediatr 157 (3): 428-433.
45. Simmat-Durand L, Lejeune C, Gourarier L, Groupe d' Etudes Grossesse et Addictions (GEGA). 2009. Pregnancy under high-dose buprenorphine. Eur J Obstet Gynecol Reprod Biol 142 (2): 119-123.
46. Stine SM, Heil SH, Kaltenbach K, et al,. 2009. Characteristics of opioid-using pregnant women who accept or refuse participation in a clinical trial: screening results from the MOTHER study. Am J Drug Alcohol Abuse 35 (6): 429-433.
47. Unger AS, Martin PR, Kaltenbach K, Stine SM, Heil SH, Jones HE, Arria AM, Coyle MG, Selby P, Fischer G,. 2010a. Clinical characteristics of central European and North American samples of pregnant women screened for opioid agonist treatment. Eur Addict Res 16 (2): 99-107.
48. Unger A, Jung E, Winklbaur B, Fischer G,. 2010b. Gender issues in the pharmacotherapy of opioid-addicted women: buprenorphine. J Addict Dis 29 (2): 217-230.
49. Unger A, Jagsch R, Jones H, et al,. 2011. Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison. Addiction 106 (7): 1355-1362.
50. Wang RIH,., Wiesen RL, Lamid S, Roh BL,. 1974. Rating the presence and severity of opiate dependence. Clin Pharmacol Ther 7: 653-658.
51. Winklbaur B, Kopf N, Ebner N, Jung E, Thau K, Fischer G,. 2008. Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates. Addiction 103: 1429-1440.